Climb Bio Financials - Benzinga

Climb Bio Inc

CLYMNASDAQ

Trade with Public

Trade with Public

$14.25

-0.70-4.68%

At close: Sep 11, 5:00 PM EST

$14.48

0.231.61%

After Hours: Sep 11, 6:43 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Climb Bio Financials

Climb Bio (CLYM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Climb Bio Q2 EPS $(0.18) Beats $(0.21) Estimate

Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 38.46 percent decrease over losses of $(0.13) per share from the

Benzinga Newsdesk

PRO
Climb Bio Q1 EPS $(0.20) Beats $(0.29) Estimate

Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.29) by 31.03 percent. This is a 35.48 percent increase over losses of $(0.31) per share from the

Benzinga Newsdesk

PRO
Climb Bio Q4 EPS $(0.26) Misses $(0.18) Estimate

Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 46.07 percent. This is a 100 percent decrease over losses of $(0.13) per share from the

Benzinga Newsdesk

PRO
Climb Bio Q3 EPS $(0.19) Misses $(0.14) Estimate

Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.14) by 31.94 percent. This is a 46.15 percent decrease over losses of $(0.13) per share from the

Benzinga Newsdesk

PRO
Climb Bio Q2 EPS $(0.13) Beats $(0.17) Estimate

Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.17) by 23.53 percent. This is a 92.82 percent increase over losses of $(1.81) per share from the

Benzinga Newsdesk

PRO
Climb Bio Q1 EPS $(0.31) Misses $(0.15) Estimate

Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.15) by 106.67 percent. This is a 416.67 percent decrease over losses of $(0.06) per share from the

Benzinga Newsdesk